Skip to main content

Table 1 Sample sizes for a range of power calculations for the composite primary outcome

From: The Magpie Trial follow up study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761]

 

25% reduction in risk of death or neurosensory disability

 

18%→13.5%

20%→15%

22%→16.5%

24%→18%

alpha 0.05, power 90%

2840

2500

2230

2000

alpha 0.05, power 80%

2140

1890

1684

1512

 

20% reduction in risk of death or neurosensory disability

 

18%→14.4%

20%→16%

22%→17.6%

24%→19.2%

alpha 0.05, power 80%

3390

2990

2664

2390

alpha 0.05, power 70%

2376

2114

2114

1896

 

15% reduction in risk of death or neurosensory disability

 

18%→15.3%

20%→17%

22%→18.7%

24%→20.4%

alpha 0.05, power 60%

3870

3410

3036

2722